Peter Motteram

Peter started in the pharmaceutical industry in GCP QA audit with Sterling Drug.  He moved to Quintiles and ran business Development for non-Americas and then Joined ClniTrials Research as General Manager also for non-Americas.  Since 1998 Peter has been consulting,.  ProActive Study Management offers project management and CRO Oversight services and training.  Peter has worked with Origin Sciences since 2015, becoming the company’s Chief Operating Officer in SEP18.  Origin Sciences has a CE marked medical device for sampling rectal mucosa and is currently investigating its use in the early detection of colorectal cancer